The Walden Group, a healthcare investment banking firm based in Tarrytown, N.Y., represented JoViPak and arranged for the transaction. Both parties agreed not to disclose the transaction details.

About BSN medical
BSN medical is a global leader in wound care and related vascular diseases, lymphology and non-invasive orthopaedic products. Founded in 2001, the company currently employs approximately 5,500 members of staff, and generated revenues of € 762m in 2014. The company aims to provide an integrated therapy-driven approach – grounded in a broad portfolio of products, enhanced by insights into current therapeutic areas and complemented by a progressive approach to partnerships. Its well-known brands such as Leukoplast®, Cutimed®, JOBST, Delta® and Actimove® are among the most trusted in healthcare. With its comprehensive product portfolio, BSN medical addresses patients’ needs in the most prevalent conditions in wound care and vascular diseases, and orthopaedic treatments. More information: www.bsnmedical.com
About JoViPak
JoViPak is a socially responsible manufacturer of products used to manage acute and chronic oedema and related venous insufficiency. The company sells compression garments, liners and pads, and has been successfully doing so for over 15 years. Founded by JoAnn Rovig, a renowned lymphoedema therapist, educator, and cancer survivor, JoViPak has been a leader in the industry since its inception. Based in Seattle, the company’s products are manufactured exclusively in the USA while JoViPak serves both the domestic and international communities. Thanks, to input from doctors, therapists and patients, the company continues to innovate and add new products to stay at the forefront of its industry. More information: www.jovipak.com

Back to HCB News

More HCB News